tag:blogger.com,1999:blog-7857054149675424609.post8621265980775577250..comments2024-02-24T08:58:08.581+00:00Comments on RNAi Therapeutics: RNAi Therapeutics Ebola Candidate Achieves Critical MilestoneDirk Hausseckerhttp://www.blogger.com/profile/18320439857875629714noreply@blogger.comBlogger6125tag:blogger.com,1999:blog-7857054149675424609.post-30618644770516092802013-05-18T07:21:52.235+00:002013-05-18T07:21:52.235+00:00True. It will be interesting though how an ALN-TT...True. It will be interesting though how an ALN-TTR label would read, e.g. would it specify the types of mutations? This could determine success with reimbursement.Dirk Hausseckerhttps://www.blogger.com/profile/18320439857875629714noreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-36766061562515118972013-05-17T17:33:08.907+00:002013-05-17T17:33:08.907+00:00Hey Dirk, this may be the most important near term...Hey Dirk, this may be the most important near term catalyst for the company. Can you explain how TKMR/ALNY TTR 02 could be used for FAC? Or would this be considered off label? In the most recent ALNY cc the CEO stated it might be up to the physician to choose. This could imply TKMR could be a huge benefactor if FAC patients choose IV over sc. And, there will be at least a year of no sc Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-27476374457305136672013-05-17T12:34:02.542+00:002013-05-17T12:34:02.542+00:00Thanks for all the insightful questions and commen...Thanks for all the insightful questions and comments. I can't answer them right now, but suffice it to say that the Ebola stockpiling opportunity is significant for a company of its size and that for Tekmira to be discovered by the general market, they will have to hire a manic salesman-type CEO and relocate to Cambridge, Mass. Tekmira is far too technology-oriented. I know it can be Dirk Hausseckerhttps://www.blogger.com/profile/18320439857875629714noreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-47359651734370821782013-05-16T18:11:43.193+00:002013-05-16T18:11:43.193+00:00Dirk ... I appreciate your work ... Thanks!
What ...Dirk ... I appreciate your work ... Thanks!<br /><br />What is the upside to Tekmira once their Ebola candidate is finally approved for D.O.D. stockpiling? Do they own the commercial rights to license distribution worldwide?<br />Do they receive a royalty on D.O.D. purchases?<br /><br />Is SRPT still under contract to the DOD? I thought that they were booted after a contract review.<br /><br />Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-64280084324092740462013-05-16T17:04:36.863+00:002013-05-16T17:04:36.863+00:00Dirk, do u have a theory y nothing moves this stoc...Dirk, do u have a theory y nothing moves this stock?Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-85980047002536020192013-05-16T12:47:32.858+00:002013-05-16T12:47:32.858+00:00Always look forward to reading your blog posts, th...Always look forward to reading your blog posts, thank you Dirk<br /><br />Just wondering if you could clarify 1 point and answer a few Q's<br />1) you wrote "Of note, the first Ebola trial were likely conducted in the absence of corticosteroid pre-treatment and it is very likely, also in light of Alnylam's recent announcement of tapering off corticosteroids in the ALN-TTR02 trial, Henrynoreply@blogger.com